Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Gregory Schwartz

Concepts (576)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
72
2025
275
16.600
 Why?
Anticholesteremic Agents
53
2025
153
12.830
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
56
2024
438
8.000
 Why?
Lipoprotein(a)
21
2025
67
7.650
 Why?
Antibodies, Monoclonal, Humanized
41
2025
803
6.780
 Why?
Cholesterol, LDL
52
2025
362
6.440
 Why?
Myocardial Infarction
44
2023
1044
5.170
 Why?
Cardiovascular Diseases
39
2024
2110
4.370
 Why?
Proprotein Convertase 9
26
2025
73
3.600
 Why?
Coronary Disease
16
2020
385
3.210
 Why?
Angina, Unstable
19
2019
76
2.920
 Why?
Heptanoic Acids
23
2016
66
2.740
 Why?
Cholesterol, HDL
13
2020
205
2.720
 Why?
Diabetes Mellitus, Type 2
23
2025
2508
2.690
 Why?
Sulfhydryl Compounds
10
2020
191
2.570
 Why?
Pyrroles
23
2016
211
2.540
 Why?
Hypercholesterolemia
11
2023
103
2.530
 Why?
Stroke
31
2023
1122
2.430
 Why?
Dyslipidemias
8
2024
177
2.390
 Why?
Quinazolinones
7
2021
19
2.230
 Why?
Serine Proteinase Inhibitors
5
2025
47
1.990
 Why?
Myocardial Ischemia
17
2018
263
1.690
 Why?
Secondary Prevention
11
2019
229
1.640
 Why?
Thiazolidinediones
10
2017
137
1.630
 Why?
Atherosclerosis
11
2024
411
1.610
 Why?
Cholesterol
12
2022
412
1.590
 Why?
Double-Blind Method
42
2024
1980
1.570
 Why?
Treatment Outcome
64
2025
10768
1.460
 Why?
Esters
9
2020
77
1.430
 Why?
Amides
9
2020
93
1.420
 Why?
Oxazoles
8
2019
37
1.400
 Why?
Cholesterol Ester Transfer Proteins
5
2016
20
1.360
 Why?
Hypoglycemic Agents
18
2024
1282
1.350
 Why?
Thiophenes
8
2019
118
1.320
 Why?
Risk Factors
45
2024
10313
1.310
 Why?
Aged
78
2025
23641
1.260
 Why?
Myocardial Contraction
14
2013
343
1.200
 Why?
Ventricular Fibrillation
3
2017
60
1.190
 Why?
Middle Aged
82
2025
33118
1.180
 Why?
Humans
170
2025
136898
1.180
 Why?
Swine
35
2023
775
1.170
 Why?
Coronary Artery Disease
6
2023
701
1.150
 Why?
Insulin Resistance
10
2018
1187
1.130
 Why?
C-Reactive Protein
11
2022
409
1.130
 Why?
Risk Assessment
20
2024
3432
1.130
 Why?
Antibodies, Monoclonal
7
2023
1417
1.100
 Why?
Metabolic Syndrome
4
2013
348
1.070
 Why?
Myocardium
23
2004
1004
1.060
 Why?
Diabetic Angiopathies
2
2019
258
1.050
 Why?
Male
105
2025
67308
1.030
 Why?
Myocardial Reperfusion Injury
5
2013
134
0.970
 Why?
Female
111
2025
72703
0.970
 Why?
Ischemic Attack, Transient
6
2018
66
0.950
 Why?
Lipoproteins, HDL
4
2019
77
0.920
 Why?
Heart
10
2009
660
0.910
 Why?
PPAR gamma
6
2022
183
0.900
 Why?
Proteins
3
2020
1012
0.890
 Why?
Proprotein Convertases
2
2014
16
0.860
 Why?
Peripheral Arterial Disease
3
2020
474
0.860
 Why?
RNA, Small Interfering
10
2024
620
0.830
 Why?
Triglycerides
5
2024
524
0.810
 Why?
Fatty Acids, Nonesterified
4
2018
159
0.740
 Why?
Biomarkers
21
2025
4148
0.730
 Why?
Patient Admission
2
2021
191
0.720
 Why?
Insulin
7
2021
2389
0.720
 Why?
Time Factors
21
2024
6802
0.700
 Why?
Coronary Circulation
18
2004
141
0.700
 Why?
Hospitalization
5
2019
2183
0.680
 Why?
Molecular Targeted Therapy
2
2014
413
0.670
 Why?
Cardiovascular Agents
4
2021
160
0.670
 Why?
Randomized Controlled Trials as Topic
18
2024
1460
0.660
 Why?
Recurrence
11
2021
1058
0.640
 Why?
Hyperlipoproteinemia Type II
3
2025
35
0.630
 Why?
Energy Metabolism
13
2004
892
0.620
 Why?
Swine, Miniature
3
2013
82
0.580
 Why?
Adiponectin
2
2018
241
0.580
 Why?
Lipid Metabolism
2
2014
509
0.580
 Why?
Heart Arrest
4
2017
335
0.570
 Why?
Venous Thrombosis
1
2020
185
0.570
 Why?
Brain Ischemia
5
2022
341
0.560
 Why?
Ezetimibe
4
2023
24
0.560
 Why?
Aldosterone
1
2017
44
0.530
 Why?
Rosuvastatin Calcium
4
2022
22
0.520
 Why?
Cardiovascular System
1
2018
141
0.510
 Why?
Venous Thromboembolism
1
2020
310
0.490
 Why?
Arteriosclerosis
2
2014
88
0.460
 Why?
Patient Readmission
2
2021
693
0.460
 Why?
Adenosine Triphosphate
14
2017
487
0.440
 Why?
Renal Insufficiency, Chronic
4
2024
608
0.440
 Why?
Drug Therapy, Combination
6
2020
1060
0.440
 Why?
Magnetic Resonance Spectroscopy
17
2019
616
0.420
 Why?
Diabetes Complications
3
2021
226
0.410
 Why?
Metformin
1
2017
327
0.410
 Why?
Animals
49
2023
36914
0.410
 Why?
Phosphocreatine
13
1995
47
0.400
 Why?
Veterans
3
2023
1446
0.400
 Why?
Atrial Fibrillation
2
2022
390
0.390
 Why?
Phosphates
7
2024
184
0.390
 Why?
Hemodynamics
11
2007
1114
0.380
 Why?
Proportional Hazards Models
9
2019
1262
0.380
 Why?
Heart Failure
9
2022
2210
0.380
 Why?
Ventricular Function, Left
9
2004
540
0.380
 Why?
Coronary Vessels
8
2012
245
0.380
 Why?
Blood Pressure
11
2012
1774
0.370
 Why?
Obesity
3
2024
2966
0.370
 Why?
Dietary Fats
2
2013
301
0.370
 Why?
Uncertainty
1
2012
125
0.370
 Why?
Drug Administration Schedule
8
2019
784
0.350
 Why?
Follow-Up Studies
11
2023
5126
0.350
 Why?
Glucose
5
2020
1018
0.340
 Why?
Reperfusion Injury
2
2005
278
0.340
 Why?
Systole
7
2001
191
0.340
 Why?
Fluorobenzenes
2
2014
16
0.340
 Why?
Research Design
3
2009
1108
0.330
 Why?
Phospholipases A2, Secretory
4
2014
12
0.320
 Why?
Risk
9
2018
905
0.320
 Why?
Diastole
5
2001
150
0.310
 Why?
Ischemia
1
2012
407
0.310
 Why?
Ventricular Dysfunction, Right
3
2007
236
0.300
 Why?
Surgical Procedures, Operative
4
2017
256
0.290
 Why?
KATP Channels
1
2008
20
0.290
 Why?
Apolipoproteins B
5
2022
43
0.290
 Why?
Cohort Studies
6
2023
5711
0.280
 Why?
Clinical Trials, Phase III as Topic
3
2024
104
0.280
 Why?
Acute Disease
9
2012
1000
0.280
 Why?
Chromans
3
2004
25
0.280
 Why?
Hypolipidemic Agents
3
2022
92
0.270
 Why?
Mortality
3
2017
357
0.270
 Why?
Survival Analysis
7
2018
1320
0.270
 Why?
Peptide Fragments
4
2024
707
0.270
 Why?
Incidence
7
2022
2783
0.270
 Why?
Dose-Response Relationship, Drug
7
2019
2066
0.270
 Why?
Veterans Health
2
2020
180
0.270
 Why?
Potassium
2
2014
151
0.260
 Why?
Cholecalciferol
1
2007
58
0.260
 Why?
Sodium
2
2020
217
0.260
 Why?
Pyrimidines
2
2014
472
0.260
 Why?
Prognosis
6
2024
4011
0.260
 Why?
Sulfonamides
2
2014
512
0.250
 Why?
Phospholipids
3
2018
223
0.250
 Why?
Subtilisins
2
2023
10
0.250
 Why?
Hyperlipoproteinemia Type III
1
2025
3
0.250
 Why?
Fenofibrate
1
2005
29
0.250
 Why?
Myelodysplastic Syndromes
1
2007
135
0.240
 Why?
Dobutamine
5
2000
39
0.240
 Why?
Oxygen Consumption
8
2000
681
0.230
 Why?
Blood Glucose
6
2024
2161
0.230
 Why?
Acetates
3
2019
100
0.230
 Why?
Disease Models, Animal
8
2013
4281
0.230
 Why?
Apolipoprotein A-I
2
2018
30
0.230
 Why?
Natriuretic Peptide, Brain
3
2024
100
0.230
 Why?
Prediabetic State
2
2020
247
0.230
 Why?
Cardiotonic Agents
3
2005
126
0.220
 Why?
Lanthanum
1
2024
13
0.220
 Why?
Adrenergic beta-Antagonists
3
2013
324
0.220
 Why?
Morbidity
5
2017
321
0.220
 Why?
Hyperemia
3
1991
49
0.220
 Why?
Syndrome
6
2007
359
0.220
 Why?
Cause of Death
5
2017
431
0.220
 Why?
Injections, Subcutaneous
2
2024
154
0.210
 Why?
Thiazoles
2
2003
122
0.210
 Why?
Phosphorylation
3
2013
1762
0.200
 Why?
Serine Endopeptidases
2
2014
123
0.200
 Why?
Isoproterenol
3
1998
116
0.200
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
17
0.200
 Why?
Lipids
3
2024
664
0.200
 Why?
Residence Characteristics
3
2016
350
0.200
 Why?
Blood Vessels
1
2024
187
0.200
 Why?
Genes, Bacterial
1
2023
165
0.200
 Why?
Calcitriol
2
2003
58
0.190
 Why?
Indoles
3
2019
411
0.190
 Why?
Calcifediol
2
2000
33
0.190
 Why?
Propensity Score
2
2021
287
0.190
 Why?
Predictive Value of Tests
5
2017
2030
0.190
 Why?
Livestock
2
2023
9
0.190
 Why?
Insulin Receptor Substrate Proteins
2
2013
59
0.180
 Why?
Prostatic Neoplasms
5
2003
1033
0.180
 Why?
Diacetyl
1
2001
7
0.180
 Why?
PPAR alpha
4
2022
59
0.180
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
220
0.180
 Why?
Cost-Benefit Analysis
2
2020
592
0.180
 Why?
Muscles
1
2022
325
0.180
 Why?
Pancreatic Neoplasms
2
2000
941
0.180
 Why?
Mental Status and Dementia Tests
1
2021
26
0.180
 Why?
Cytokines
2
2005
2078
0.170
 Why?
Apolipoproteins
3
2012
33
0.170
 Why?
Myocardial Reperfusion
1
2000
50
0.170
 Why?
Cataract
1
2023
213
0.170
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
75
0.170
 Why?
Coronary Artery Bypass
2
2019
237
0.170
 Why?
Calpain
2
2012
59
0.160
 Why?
Lipoproteins, LDL
2
2014
119
0.160
 Why?
Perioperative Care
2
2017
182
0.160
 Why?
Matrix Metalloproteinases
1
2000
94
0.160
 Why?
Cadmium
1
2000
70
0.160
 Why?
Oncogenes
1
2000
117
0.160
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
278
0.160
 Why?
Renin-Angiotensin System
1
2019
84
0.150
 Why?
Proto-Oncogene Proteins c-akt
2
2013
437
0.150
 Why?
Alkaline Phosphatase
1
2019
148
0.150
 Why?
United States
7
2023
14595
0.150
 Why?
Adenylyl Cyclases
2
2016
87
0.150
 Why?
Early Termination of Clinical Trials
2
2015
16
0.150
 Why?
Immunoturbidimetry
1
2018
1
0.150
 Why?
Multifactorial Inheritance
1
2019
174
0.150
 Why?
Carotid Artery Diseases
1
2018
66
0.140
 Why?
Risk Reduction Behavior
1
2020
219
0.140
 Why?
Adrenergic beta-Agonists
1
1998
133
0.140
 Why?
Collagen
1
2000
446
0.140
 Why?
American Heart Association
1
2019
306
0.140
 Why?
Oxidative Stress
1
2024
1302
0.140
 Why?
Environment
2
2016
362
0.140
 Why?
Citrate (si)-Synthase
1
2017
60
0.140
 Why?
Ponds
1
2016
14
0.130
 Why?
Microalgae
1
2016
10
0.130
 Why?
Pharmacogenetics
2
2016
179
0.130
 Why?
Transcription Factors
2
2016
1715
0.130
 Why?
Prostate
1
1998
175
0.130
 Why?
Hypertension, Pulmonary
3
2012
1901
0.130
 Why?
Aged, 80 and over
8
2020
7552
0.130
 Why?
Percutaneous Coronary Intervention
2
2019
478
0.130
 Why?
Waste Disposal, Fluid
1
2016
50
0.130
 Why?
Administration, Intravenous
1
2017
152
0.130
 Why?
HIV Long Terminal Repeat
1
2016
11
0.130
 Why?
Global Health
2
2017
384
0.130
 Why?
Drug Design
1
2017
170
0.130
 Why?
tat Gene Products, Human Immunodeficiency Virus
1
2016
24
0.130
 Why?
Inflammation
6
2016
2817
0.130
 Why?
Australia
4
2019
313
0.130
 Why?
Lipoproteins
2
2014
166
0.130
 Why?
Postoperative Complications
2
2019
2627
0.130
 Why?
Simvastatin
2
2015
61
0.130
 Why?
Inflammation Mediators
2
2013
514
0.130
 Why?
HIV Envelope Protein gp120
1
2016
60
0.130
 Why?
Signal Transduction
1
2009
5077
0.120
 Why?
Clinical Trials as Topic
2
2018
1037
0.120
 Why?
Epigenesis, Genetic
1
2021
658
0.120
 Why?
Anti-Arrhythmia Agents
2
2012
115
0.120
 Why?
AMP-Activated Protein Kinases
1
2017
193
0.120
 Why?
Platelet Aggregation Inhibitors
1
2019
454
0.120
 Why?
Heart Ventricles
6
2012
792
0.120
 Why?
ATP Binding Cassette Transporter 1
1
2015
11
0.120
 Why?
Chromosomes, Human, Pair 16
1
2015
36
0.120
 Why?
Hospital Mortality
1
2019
901
0.120
 Why?
Recombinant Proteins
1
2018
1357
0.120
 Why?
Diet
2
2013
1261
0.120
 Why?
Vasodilation
2
2013
494
0.120
 Why?
Wireless Technology
1
2014
13
0.110
 Why?
Bacteria
2
2023
855
0.110
 Why?
Homeostasis
1
2018
622
0.110
 Why?
Linkage Disequilibrium
1
2015
268
0.110
 Why?
Transistors, Electronic
1
2014
9
0.110
 Why?
Serum Amyloid A Protein
3
2013
32
0.110
 Why?
Smoking
2
2000
1633
0.110
 Why?
Stents
1
2018
524
0.110
 Why?
Endovascular Procedures
1
2018
310
0.110
 Why?
Seawater
1
2014
31
0.110
 Why?
Disease Progression
4
2018
2744
0.110
 Why?
Ions
1
2014
72
0.110
 Why?
Heart Rate
5
2001
830
0.110
 Why?
Fresh Water
1
2014
57
0.110
 Why?
Phospholipases A
1
2014
102
0.110
 Why?
Metals, Heavy
1
2014
32
0.110
 Why?
Commerce
1
2014
80
0.100
 Why?
Adult
13
2024
37595
0.100
 Why?
Fasting
1
2015
276
0.100
 Why?
Mendelian Randomization Analysis
1
2013
50
0.100
 Why?
Acyl Coenzyme A
1
2013
31
0.100
 Why?
Heart Function Tests
1
2013
61
0.100
 Why?
Ventricular Function, Right
1
1995
283
0.100
 Why?
Ultraviolet Rays
2
1992
389
0.100
 Why?
Hydroxy Acids
1
2012
4
0.100
 Why?
Monitoring, Physiologic
1
2014
267
0.100
 Why?
Decanoic Acids
1
2012
8
0.100
 Why?
Ischemic Preconditioning, Myocardial
1
2012
30
0.100
 Why?
Talin
1
2012
9
0.100
 Why?
Potassium Channel Blockers
1
2012
37
0.100
 Why?
Glyburide
1
2012
32
0.100
 Why?
Cardiolipins
1
2013
85
0.100
 Why?
Retrospective Studies
6
2018
15514
0.100
 Why?
Nitric Oxide Synthase Type III
1
2013
203
0.100
 Why?
Biosensing Techniques
1
2014
127
0.100
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
22
0.090
 Why?
North America
3
2019
312
0.090
 Why?
Case-Control Studies
1
2019
3528
0.090
 Why?
Europe
3
2019
413
0.090
 Why?
Polymorphism, Genetic
1
2015
652
0.090
 Why?
Prospective Studies
2
2021
7543
0.090
 Why?
Keto Acids
3
2019
13
0.090
 Why?
Practice Guidelines as Topic
1
2019
1575
0.090
 Why?
Tissue Plasminogen Activator
2
2013
225
0.090
 Why?
DNA
2
2013
1460
0.090
 Why?
Arteries
1
2013
269
0.090
 Why?
Hypertension
1
2000
1291
0.090
 Why?
Genetic Variation
1
2016
986
0.090
 Why?
Death, Sudden, Cardiac
1
2012
184
0.090
 Why?
MAP Kinase Signaling System
1
2013
322
0.090
 Why?
Manure
2
2023
8
0.090
 Why?
Electrocardiography
3
2011
632
0.080
 Why?
Myocardial Revascularization
3
2017
73
0.080
 Why?
Fractures, Bone
1
2016
416
0.080
 Why?
Prejudice
1
2011
74
0.080
 Why?
United States Department of Veterans Affairs
3
2016
667
0.080
 Why?
Phosphorus
5
1995
97
0.080
 Why?
HIV-1
1
2016
862
0.080
 Why?
Down-Regulation
2
2024
658
0.080
 Why?
Polymers
1
2014
495
0.080
 Why?
Gene Expression Regulation
2
2013
2615
0.080
 Why?
Critical Care
1
2014
583
0.080
 Why?
RNA, Messenger
3
2015
2837
0.080
 Why?
Age Factors
3
2011
3290
0.080
 Why?
Feeding Behavior
1
2014
648
0.070
 Why?
Macrophages
1
2016
1547
0.070
 Why?
Vitamin D Deficiency
1
1990
182
0.070
 Why?
Neoplasms
1
2023
2655
0.070
 Why?
Vascular Diseases
2
2022
244
0.070
 Why?
MicroRNAs
1
2015
703
0.070
 Why?
Ventricular Pressure
1
2007
48
0.070
 Why?
Diabetes Mellitus
1
2016
1033
0.070
 Why?
Equipment Design
3
2014
523
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
366
0.070
 Why?
Vitamin D
3
2000
392
0.070
 Why?
Models, Biological
1
2014
1774
0.070
 Why?
Ultrasonography, Interventional
2
2018
142
0.070
 Why?
Angiomatosis
1
2006
5
0.060
 Why?
Kaplan-Meier Estimate
2
2020
892
0.060
 Why?
Survival Rate
1
2011
1972
0.060
 Why?
Hemangioma, Capillary
1
2006
13
0.060
 Why?
Reactive Oxygen Species
1
2009
619
0.060
 Why?
Lactic Acid
2
1998
306
0.060
 Why?
Angina Pectoris
2
2004
66
0.060
 Why?
Anti-Inflammatory Agents
1
2009
498
0.060
 Why?
Ultrasonography
1
2009
749
0.060
 Why?
Apolipoproteins E
1
2025
84
0.060
 Why?
Cerebrovascular Disorders
2
2017
96
0.060
 Why?
Liver
2
2024
1937
0.060
 Why?
Chronic Disease
1
2011
1773
0.060
 Why?
Sus scrofa
1
2004
52
0.060
 Why?
alpha-Tocopherol
1
2004
33
0.060
 Why?
Arterial Occlusive Diseases
2
1982
81
0.060
 Why?
Heterozygote
1
2025
291
0.060
 Why?
Administration, Oral
1
2007
811
0.060
 Why?
Linear Models
2
2013
850
0.060
 Why?
Antigen-Antibody Complex
1
2004
90
0.060
 Why?
CD40 Ligand
1
2004
41
0.060
 Why?
Least-Squares Analysis
1
2004
79
0.060
 Why?
Economics, Pharmaceutical
1
2003
9
0.050
 Why?
Multicenter Studies as Topic
2
2012
303
0.050
 Why?
Ergocalciferols
1
2003
12
0.050
 Why?
Muscular Diseases
1
2004
114
0.050
 Why?
Regional Blood Flow
3
1996
474
0.050
 Why?
Radiation-Sensitizing Agents
1
2003
42
0.050
 Why?
Tumor Cells, Cultured
3
2003
950
0.050
 Why?
Comorbidity
2
2019
1611
0.050
 Why?
Lactates
2
1994
85
0.050
 Why?
Guidelines as Topic
1
2005
277
0.050
 Why?
beta-Lactams
1
2023
34
0.050
 Why?
Death
2
2019
119
0.050
 Why?
Angiotensin Receptor Antagonists
1
2023
92
0.050
 Why?
Creatine Kinase
1
2022
79
0.050
 Why?
Drug Resistance, Bacterial
1
2023
180
0.050
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2023
202
0.050
 Why?
Pharmacogenomic Testing
1
2022
65
0.050
 Why?
Multivariate Analysis
2
2017
1524
0.050
 Why?
Verapamil
1
2001
41
0.040
 Why?
Goals
1
2022
168
0.040
 Why?
Organ Preservation Solutions
1
2001
46
0.040
 Why?
Controlled Clinical Trials as Topic
1
2000
28
0.040
 Why?
Oxidation-Reduction
3
2012
1059
0.040
 Why?
Antioxidants
1
2004
577
0.040
 Why?
Receptors, Immunologic
1
2022
223
0.040
 Why?
Ventricular Dysfunction
1
2000
16
0.040
 Why?
Myocardial Stunning
1
2000
5
0.040
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
18
0.040
 Why?
Collagenases
1
2000
25
0.040
 Why?
Hexamethonium
1
2000
4
0.040
 Why?
Atropine
1
2000
24
0.040
 Why?
Arrhythmias, Cardiac
1
2003
331
0.040
 Why?
Health Care Costs
1
2003
386
0.040
 Why?
Dilatation, Pathologic
1
2000
61
0.040
 Why?
Soil Microbiology
1
2023
218
0.040
 Why?
Louisiana
1
2000
29
0.040
 Why?
Liver Cirrhosis
1
2022
316
0.040
 Why?
Dipeptides
2
2012
50
0.040
 Why?
Interleukin-6
3
2013
771
0.040
 Why?
Occupations
1
2000
48
0.040
 Why?
Pericardium
1
2000
56
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
132
0.040
 Why?
Cell Line
2
2016
2847
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
389
0.040
 Why?
Blood Chemical Analysis
1
2020
98
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
75
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
Placebo Effect
1
2019
56
0.040
 Why?
New Zealand
1
2019
55
0.040
 Why?
Antigens, CD
1
2022
524
0.040
 Why?
Insulin Antagonists
1
1998
8
0.040
 Why?
Ventricular Function
1
1999
61
0.040
 Why?
Logistic Models
1
2004
2060
0.040
 Why?
Hormone Antagonists
1
1998
34
0.040
 Why?
Hungary
1
2018
4
0.040
 Why?
Drug Combinations
1
2000
339
0.040
 Why?
Somatostatin
1
1998
62
0.040
 Why?
Sex Characteristics
1
2024
766
0.040
 Why?
Placebos
1
2019
207
0.040
 Why?
India
1
2019
193
0.040
 Why?
Infusion Pumps
1
2018
32
0.040
 Why?
Israel
1
2018
58
0.040
 Why?
Pulmonary Artery
2
2006
1084
0.040
 Why?
Microscopy, Electron
1
1999
434
0.040
 Why?
Netherlands
1
2018
88
0.040
 Why?
Florida
1
1998
101
0.040
 Why?
Elasticity
1
1999
195
0.040
 Why?
Protective Factors
1
2018
94
0.040
 Why?
Drug Interactions
1
2019
409
0.040
 Why?
Sex Factors
1
2024
2067
0.040
 Why?
Blood Flow Velocity
1
1999
412
0.030
 Why?
Echocardiography, Transesophageal
1
1997
97
0.030
 Why?
Selection Bias
1
2017
37
0.030
 Why?
Erythrocytes
1
2022
692
0.030
 Why?
Drug Evaluation, Preclinical
1
2017
183
0.030
 Why?
Poverty Areas
1
2016
39
0.030
 Why?
Catheterization
1
1997
178
0.030
 Why?
Urban Health
1
2016
92
0.030
 Why?
Cardiac Catheterization
1
2000
528
0.030
 Why?
Chi-Square Distribution
1
2017
533
0.030
 Why?
Rural Health
1
2016
79
0.030
 Why?
Pharmacogenomic Variants
1
2016
35
0.030
 Why?
Drug Discovery
1
2017
141
0.030
 Why?
Viral Tropism
1
2016
30
0.030
 Why?
Internationality
1
2017
155
0.030
 Why?
Drug Industry
1
2017
109
0.030
 Why?
Receptors, CCR5
1
2016
59
0.030
 Why?
Albuminuria
1
2017
185
0.030
 Why?
Receptors, CXCR4
1
2016
85
0.030
 Why?
Attitude of Health Personnel
1
2004
1160
0.030
 Why?
CD4 Antigens
1
2016
141
0.030
 Why?
Troponin
2
2007
51
0.030
 Why?
Body Mass Index
1
2024
2351
0.030
 Why?
Immunoglobulin M
2
2009
287
0.030
 Why?
Membrane Proteins
1
2022
1167
0.030
 Why?
Fatty Acids
1
1998
443
0.030
 Why?
Cognitive Dysfunction
1
2021
383
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
140
0.030
 Why?
Myalgia
1
2015
13
0.030
 Why?
Genome-Wide Association Study
1
2022
1434
0.030
 Why?
Physicians
1
2004
902
0.030
 Why?
Receptors, LDL
1
2015
49
0.030
 Why?
Creatinine
1
2017
500
0.030
 Why?
Electromagnetic Radiation
1
2014
3
0.030
 Why?
Quality of Life
1
2007
2847
0.030
 Why?
Thrombolytic Therapy
1
1996
145
0.030
 Why?
Lidocaine
1
1994
42
0.030
 Why?
Myositis
1
2015
52
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
392
0.030
 Why?
Social Class
1
2016
277
0.030
 Why?
Adenosine
2
1994
227
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
91
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
30
0.030
 Why?
Electric Stimulation
1
1995
272
0.030
 Why?
Calibration
1
2014
146
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
130
0.030
 Why?
Osmolar Concentration
1
1994
174
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
138
0.030
 Why?
Analysis of Variance
1
2017
1324
0.030
 Why?
Seasons
1
2016
540
0.030
 Why?
Semiconductors
1
2014
40
0.030
 Why?
Stroke Volume
1
1997
611
0.030
 Why?
Adenosine Diphosphate
1
1994
79
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2000
1400
0.030
 Why?
Mice
3
2016
17775
0.030
 Why?
Pressure
1
2014
243
0.030
 Why?
NAD
1
1994
77
0.030
 Why?
Solutions
1
2014
170
0.030
 Why?
Glycine
1
1994
175
0.030
 Why?
Mitochondria, Heart
1
1994
100
0.030
 Why?
Hyperglycemia
1
2017
344
0.030
 Why?
Patient Outcome Assessment
1
2014
132
0.030
 Why?
Perioperative Period
1
2013
56
0.030
 Why?
Glomerular Filtration Rate
1
2017
739
0.030
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
39
0.030
 Why?
Materials Testing
1
2014
357
0.030
 Why?
Oxidative Phosphorylation
1
1994
193
0.030
 Why?
Binding Sites
1
2016
1308
0.020
 Why?
Dose-Response Relationship, Radiation
1
1992
141
0.020
 Why?
Heparin
1
1994
259
0.020
 Why?
Immunoglobulin G
2
2009
886
0.020
 Why?
Dogs
3
1984
411
0.020
 Why?
Anti-Bacterial Agents
1
2023
1790
0.020
 Why?
Nutrition Surveys
1
2014
267
0.020
 Why?
Actinin
1
2012
13
0.020
 Why?
South Africa
1
2013
219
0.020
 Why?
Weight Gain
1
2016
518
0.020
 Why?
Socioeconomic Factors
1
2016
1279
0.020
 Why?
Patient Selection
1
1996
690
0.020
 Why?
Cardiac Output, Low
1
1992
66
0.020
 Why?
Mathematics
1
1992
111
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
346
0.020
 Why?
Vascular Resistance
2
1984
372
0.020
 Why?
Cardiomyopathy, Dilated
2
1992
383
0.020
 Why?
Reperfusion
1
1991
40
0.020
 Why?
Perfusion
1
1992
212
0.020
 Why?
Biopsy
1
1995
1130
0.020
 Why?
Cross-Sectional Studies
2
2014
5398
0.020
 Why?
Disease-Free Survival
1
2013
690
0.020
 Why?
Anticoagulants
1
1996
662
0.020
 Why?
Poisson Distribution
1
2011
75
0.020
 Why?
Georgia
1
2011
84
0.020
 Why?
Constriction
1
1990
48
0.020
 Why?
Vitamin D-Binding Protein
1
1990
15
0.020
 Why?
Patient Discharge
1
2017
887
0.020
 Why?
Alleles
1
2013
888
0.020
 Why?
Cells, Cultured
1
1998
4204
0.020
 Why?
Hypoglycemia
1
2015
442
0.020
 Why?
Regression Analysis
1
1992
1026
0.020
 Why?
Cognition Disorders
1
2014
517
0.020
 Why?
Cell Division
2
2003
795
0.020
 Why?
Autoantibodies
2
2009
1498
0.020
 Why?
Young Adult
2
2016
13157
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
84
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
2175
0.020
 Why?
Educational Status
1
2011
482
0.020
 Why?
Thromboembolism
1
2009
119
0.020
 Why?
Densitometry
1
2007
34
0.020
 Why?
Spectrin
1
2007
14
0.020
 Why?
Desmin
1
2007
24
0.020
 Why?
Environmental Exposure
1
1992
571
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
38
0.020
 Why?
Databases, Factual
1
2013
1345
0.020
 Why?
Poverty
1
2011
519
0.020
 Why?
Heart Diseases
1
1990
359
0.020
 Why?
Calcium-Binding Proteins
1
2007
218
0.020
 Why?
Kidney
1
2014
1460
0.020
 Why?
ROC Curve
1
2007
543
0.020
 Why?
Fatal Outcome
1
2006
305
0.010
 Why?
Apolipoprotein B-100
1
2004
10
0.010
 Why?
Protein Processing, Post-Translational
1
2007
471
0.010
 Why?
Aminophylline
1
1984
10
0.010
 Why?
Vasomotor System
1
1984
46
0.010
 Why?
Solubility
1
2004
248
0.010
 Why?
Mice, Inbred C57BL
1
2014
5766
0.010
 Why?
Radiation, Ionizing
1
2003
81
0.010
 Why?
DNA, Neoplasm
1
2003
165
0.010
 Why?
Health Care Surveys
1
2004
565
0.010
 Why?
Immunohistochemistry
1
2006
1739
0.010
 Why?
Odds Ratio
1
2004
1063
0.010
 Why?
Electrophysiology
1
1982
221
0.010
 Why?
Echocardiography
2
1997
659
0.010
 Why?
Vascular Surgical Procedures
1
2004
298
0.010
 Why?
Blotting, Western
1
2003
1227
0.010
 Why?
Mixed Function Oxygenases
1
2000
44
0.010
 Why?
Chemoprevention
1
2000
93
0.010
 Why?
Adolescent
2
2016
21402
0.010
 Why?
Hydrogen-Ion Concentration
2
1991
566
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2000
974
0.010
 Why?
Thorax
1
1997
47
0.010
 Why?
Phosphorus Isotopes
1
1995
7
0.010
 Why?
Infusions, Parenteral
1
1994
38
0.010
 Why?
Basal Metabolism
1
1994
60
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
87
0.010
 Why?
Apoptosis
1
2003
2542
0.010
 Why?
Substrate Specificity
1
1995
385
0.010
 Why?
T-Lymphocytes
1
2002
1996
0.010
 Why?
Glycolysis
1
1995
319
0.010
 Why?
Lung
1
2006
4046
0.010
 Why?
Stimulation, Chemical
1
1992
65
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2500
0.010
 Why?
Diphosphoglyceric Acids
1
1991
4
0.010
 Why?
Radio Waves
1
1991
18
0.010
 Why?
2,3-Diphosphoglycerate
1
1991
32
0.010
 Why?
Cardiomegaly
1
1990
175
0.000
 Why?
Rats
1
1997
5675
0.000
 Why?
Heart Block
1
1984
41
0.000
 Why?
Theophylline
1
1984
68
0.000
 Why?
Oxygen
1
1984
943
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3710
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (576) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)